Abstract:Cytochrome P450scc (CYP11A1) can hydroxylate vitamin D3 producing 20S-hydroxyvitamin D3 [20(OH)D3] and 20S,23-dihydroxyvitamin D3 [20,23(OH)2D3] as the major metabolites. These are biologically active acting as partial vitamin D receptor [VDR] agonists. Minor products include 17-hydroxyvitamin D3, 17,20-dihydroxyvitamin D3 and 17,20,23trihydroxyvitamin D3. In the current study we have further analyzed the reaction products from P450scc action on vitamin D3 and have identified two 22-hydroxy-derivatives as products, 22hydroxyvitamin D3 [22(OH)D3] and 20S,22-dihydroxyvitamin D3 [20,22(OH)2D3]. The structures of both of these derivatives were determined by NMR. P450scc could convert purified 22(OH)D3 to 20,22(OH)2D3. The 20,22(OH)2D3 could also be produced from 20(OH)D3 and was metabolized to a trihydroxyvitamin D3 product. We compared the biological activities of these new derivatives to those of 20(OH)D3, 20,23(OH)2D3 and 1α,25-dihydroxyvitamin D3 [1,25(OH)2D3]. 1,25(OH)2D3, 20(OH)D3, 22(OH)D3, 20,23(OH)2D3 and 20,22(OH)2D3 significantly inhibited keratinocyte proliferation in a dose dependent manner. The strongest inducers of involucrin expression (a marker of keratinocyte differentiation) were 20,23(OH)2D3, 20,22(OH)2D3, 20(OH)D3 and 1,25(OH)2D3, with 22(OH)D3 having a heterogeneous effect. Little or no stimulation of CYP24 mRNA expression was observed for all the analogues tested except for 1,25(OH)2D3. All the compounds stimulated VDR translocation from the cytoplasm to the nucleus with 22(OH)D3 and 20,22(OH)2D3 having less effect than 1,25(OH)2D3 and 20(OH)D3. Thus we have identified 22(OH)D3 and 20,22(OH)2D3 as products of CYP11A1 action on vitamin D3 and shown that like 20(OH)D3 and 20,23(OH)2D3, they are active on keratinocytes via the VDR, however, showing a degree of phenotypic heterogeneity in comparison to other P450scc-derived hydroxy-metabolites of vitamin D3. DMD #40071 This article has not been copyedited and formatted. The final version may differ from this version. DMD Fast Forward. Published on June 15, 2011 as DOI: 10.1124/dmd.111.040071 at A PE T Jornals on M arch 6, 2022 dm d.aspurnals.org D ow nladed from

Synthesis and Biological Evaluation of Vitamin D3 Metabolite 20S,23s-Dihydroxyvitamin D3 and Its 23r Epimer

Chemical Synthesis and Biological Activities of 20S,24s/r-Dihydroxyvitamin D3 Epimers and Their 1Α-Hydroxyl Derivatives

Chemical synthesis, biological activities and action on nuclear receptors of 20S(OH)D3, 20S,25(OH)2D3, 20S,23S(OH)2D3 and 20S,23R(OH)2D3

1Α,20s-Dihydroxyvitamin D3 Interacts with Vitamin D Receptor: Crystal Structure and Route of Chemical Synthesis

Total Synthesis of Biologically Active 20S-Hydroxyvitamin D3

4-Hydroxy-1α,25-Dihydroxyvitamin D3: Synthesis and Structure–Function Study

Novel vitamin D analogs as potential therapeutics: metabolism, toxicity profiling, and antiproliferative activity.

Design, Synthesis and Biological Activities of Novel Gemini 20S-Hydroxyvitamin D3 Analogs.

Investigation of 20S-Hydroxyvitamin D3 Analogs and Their 1Α-Oh Derivatives As Potent Vitamin D Receptor Agonists with Anti-Inflammatory Activities

Design, synthesis, and biological activity of D-bishomo-1α,25-dihydroxyvitamin D 3 analogs and their crystal structures with the vitamin D nuclear receptor

Synthesis of 1 Α, 25-Dihydroxyvitamin D3

Ultra-high-performance Liquid Chromatography-Tandem Mass Spectrometry Analysis of Serum Metabolomic Characteristics in People with Different Vitamin D Levels

26,27-Dihomo-1 alpha-hydroxy- and 26,27-dihomo-24-epi-1 alpha,25-dihydroxyvitamin D2 analogs that differ markedly in biological activity in vivo.

Discovery and Structural Analysis of Metabolites of Vitamin D3 Lactones

In vivo production of novel vitamin D2 hydroxy-derivatives by human placentas, epidermal keratinocytes, Caco-2 colon cells and the adrenal gland.

[Biosynthesis of calcifediol and calcitriol: a review]

Design and Synthesis of Novel Dehydroepiandrosterone Analogues As Potent Antiproliferative Agents

The Synthesis Of 19-Nor-1 Alpha, 25-Dihydroxy-22-Oxo-Vitamin D-3

Metabolic activation of tachysterol3 to biologically active hydroxyderivatives that act on VDR, AhR, LXRs, and PPARγ receptors

Microsoft Word-31088317-file00

Biological Effects of CYP11A1-Derived Vitamin D and Lumisterol Metabolites in the Skin